# Growth Hormone Treatment in Children Born Small for Gestational Age (SGA)

> **NCT00184717** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 98 (actual)

## Conditions studied

- Foetal Growth Problem
- Small for Gestational Age

## Interventions

- **DRUG:** somatropin
- **DRUG:** somatropin

## Key facts

- **NCT ID:** NCT00184717
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08-18
- **Primary completion:** 2006-03-29
- **Final completion:** 2009-12-28
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2017-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00184717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00184717, "Growth Hormone Treatment in Children Born Small for Gestational Age (SGA)". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00184717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*